GNCA
Vanguard Group’s Genocea Biosciences, Inc. GNCA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,574,979
| Closed | -$1.97M | – | 4698 |
|
|
2022
Q1 | $1.97M | Buy |
1,574,979
+100
| +0% | +$125 | ﹤0.01% | 3965 |
|
|
2021
Q4 | $1.83M | Buy |
1,574,879
+11,778
| +0.8% | +$13.7K | ﹤0.01% | 4079 |
|
|
2021
Q3 | $3M | Buy |
1,563,101
+24,638
| +2% | +$47.3K | ﹤0.01% | 3914 |
|
|
2021
Q2 | $3.6M | Sell |
1,538,463
-78,581
| -5% | -$184K | ﹤0.01% | 3758 |
|
|
2021
Q1 | $4.38M | Buy |
1,617,044
+6,218
| +0.4% | +$16.9K | ﹤0.01% | 3598 |
|
|
2020
Q4 | $3.9M | Sell |
1,610,826
-7,860
| -0.5% | -$19K | ﹤0.01% | 3467 |
|
|
2020
Q3 | $3.71M | Buy |
1,618,686
+834,718
| +106% | +$1.91M | ﹤0.01% | 3289 |
|
|
2020
Q2 | $1.8M | Buy |
783,968
+12,546
| +2% | +$28.9K | ﹤0.01% | 3458 |
|
|
2020
Q1 | $1.33M | Sell |
771,422
-500
| -0.1% | -$860 | ﹤0.01% | 3421 |
|
|
2019
Q4 | $1.6M | Hold |
771,922
| – | – | ﹤0.01% | 3510 |
|
|
2019
Q3 | $2.24M | Buy |
771,922
+20,545
| +3% | +$59.6K | ﹤0.01% | 3417 |
|
|
2019
Q2 | $2.95M | Sell |
751,377
-581,074
| -44% | -$2.28M | ﹤0.01% | 3353 |
|
|
2019
Q1 | $786K | Buy |
1,332,451
+29,538
| +2% | +$17.4K | ﹤0.01% | 3690 |
|
|
2018
Q4 | $374K | Sell |
1,302,913
-836,411
| -39% | -$240K | ﹤0.01% | 3792 |
|
|
2018
Q3 | $1.67M | Buy |
2,139,324
+13,374
| +0.6% | +$10.4K | ﹤0.01% | 3588 |
|
|
2018
Q2 | $1.82M | Sell |
2,125,950
-118,325
| -5% | -$101K | ﹤0.01% | 3530 |
|
|
2018
Q1 | $2.36M | Buy |
2,244,275
+1,418,427
| +172% | +$1.49M | ﹤0.01% | 3404 |
|
|
2017
Q4 | $958K | Sell |
825,848
-122,799
| -13% | -$142K | ﹤0.01% | 3619 |
|
|
2017
Q3 | $1.39M | Buy |
948,647
+91,885
| +11% | +$134K | ﹤0.01% | 3501 |
|
|
2017
Q2 | $4.47M | Buy |
856,762
+104,790
| +14% | +$547K | ﹤0.01% | 3125 |
|
|
2017
Q1 | $4.58M | Buy |
751,972
+77,052
| +11% | +$469K | ﹤0.01% | 3084 |
|
|
2016
Q4 | $2.78M | Sell |
674,920
-11,065
| -2% | -$45.6K | ﹤0.01% | 3248 |
|
|
2016
Q3 | $3.51M | Buy |
685,985
+29,470
| +4% | +$151K | ﹤0.01% | 3165 |
|
|
2016
Q2 | $2.69M | Buy |
656,515
+57,062
| +10% | +$234K | ﹤0.01% | 3256 |
|
|
2016
Q1 | $4.64M | Buy |
599,453
+7,642
| +1% | +$59.2K | ﹤0.01% | 2990 |
|
|
2015
Q4 | $3.12M | Buy |
591,811
+71,623
| +14% | +$377K | ﹤0.01% | 3214 |
|
|
2015
Q3 | $3.56M | Buy |
520,188
+196,851
| +61% | +$1.35M | ﹤0.01% | 3122 |
|
|
2015
Q2 | $4.44M | Buy |
323,337
+58,524
| +22% | +$803K | ﹤0.01% | 3066 |
|
|
2015
Q1 | $3.14M | Buy |
264,813
+149,364
| +129% | +$1.77M | ﹤0.01% | 3215 |
|
|
2014
Q4 | $808K | Buy |
115,449
+1,856
| +2% | +$13K | ﹤0.01% | 3599 |
|
|
2014
Q3 | $1.03M | Buy |
113,593
+22,896
| +25% | +$207K | ﹤0.01% | 3497 |
|
|
2014
Q2 | $1.7M | Buy |
90,697
+2,440
| +3% | +$45.8K | ﹤0.01% | 3328 |
|
|
2014
Q1 | $1.61M | Buy |
+88,257
| New | +$1.61M | ﹤0.01% | 3314 |
|